ZyCoV-D to be initially administered in seven states
The three doses of ZyCoV-D are to be administered 28 days apart. The vaccine was given emergency use authorisation (EUA) by the Indian drug regulator on August 20
The three doses of ZyCoV-D are to be administered 28 days apart. The vaccine was given emergency use authorisation (EUA) by the Indian drug regulator on August 20
Vaccine effectiveness of complete vaccination against the moderate-to-severe disease was at 81 per cent
Researchers observed that the Pfizer/BioNTech and Moderna vaccines were 78% and 73% effective in preventing Covid-19 infections, respectively
The Omicron variant doesn't escape RTPCR and RAT; States advised to ramp up testing for prompt and early identification of any cases
Booster dose is available to all residents aged 18+ and can be applied six months after the second dose of any other vaccine administered in UAE
One-shot Sputnik Light is a highly effective vaccine when used both on standalone basis and applied as a booster
The loan will fund at least 667 million Covid-19 vaccine doses for an estimated 317 million people
Featuring identity verification using artificial intelligence (AI), LabPort was designed to facilitate immediate results reporting for diagnostic testing even in high-volume, field-based testing environments
This is a shot in the arm for the vaccine manufacturers
The vaccine will be manufactured and marketed in the Philippines by SII under the brand name Covovax
Subscribe To Our Newsletter & Stay Updated